Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Response to Berlaimont and Welby.

Checchi M, Mesher D, Mohammed H, Soldan K.

Sex Transm Infect. 2019 Nov;95(7):553. doi: 10.1136/sextrans-2019-054148. Epub 2019 Jul 18. No abstract available.

PMID:
31320395
2.

HPV vaccination of gay, bisexual and other men who have sex with men in sexual health and HIV clinics in England: vaccination uptake and attendances during the pilot phase.

Checchi M, Mesher D, McCall M, Coukan F, Chau C, Mohammed H, Duffell S, Edelstein M, Yarwood J, Soldan K.

Sex Transm Infect. 2019 Dec;95(8):608-613. doi: 10.1136/sextrans-2018-053923. Epub 2019 Apr 26.

PMID:
31028226
3.

Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017.

Edelstein M, Iyanger N, Hennessy N, Mesher D, Checchi M, Soldan K, McCall M, Nugent J, Crofts J, Lo J, Gilson R, Powell K, Ramsay M, Yarwood J.

Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.8.1800055.

4.

Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.

Checchi M, Mesher D, Mohammed H, Soldan K.

Sex Transm Infect. 2019 Aug;95(5):368-373. doi: 10.1136/sextrans-2018-053751. Epub 2019 Feb 5.

PMID:
30723186
5.

Epidemiology of genital warts in the British population: implications for HPV vaccination programmes.

Sonnenberg P, Tanton C, Mesher D, King E, Beddows S, Field N, Mercer CH, Soldan K, Johnson AM.

Sex Transm Infect. 2019 Aug;95(5):386-390. doi: 10.1136/sextrans-2018-053786. Epub 2019 Feb 5.

6.

The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.

Mesher D, Panwar K, Thomas SL, Edmundson C, Choi YH, Beddows S, Soldan K.

J Infect Dis. 2018 Aug 14;218(6):911-921. doi: 10.1093/infdis/jiy249.

PMID:
29917082
7.

Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England.

Mendes D, Mesher D, Pista A, Baguelin M, Jit M.

Eur J Public Health. 2018 Apr 1;28(2):343-347. doi: 10.1093/eurpub/ckx176.

8.

Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types.

Tanton C, Mesher D, Beddows S, Soldan K, Clifton S, Panwar K, Field N, Mercer CH, Johnson AM, Sonnenberg P.

Papillomavirus Res. 2017 Jun;3:36-41. doi: 10.1016/j.pvr.2017.01.001.

9.

Attendance of MSM at Genitourinary Medicine services in England: implications for selective HPV vaccination programme (a short communication).

Bayley J, Mesher D, Nadarzynski T, Hughes G, Soldan K.

Sex Transm Infect. 2018 Nov;94(7):542-544. doi: 10.1136/sextrans-2016-052912. Epub 2017 Mar 9.

PMID:
28280237
10.

Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men.

Lin A, Ong KJ, Hobbelen P, King E, Mesher D, Edmunds WJ, Sonnenberg P, Gilson R, Bains I, Choi YH, Tanton C, Soldan K, Jit M.

Clin Infect Dis. 2017 Mar 1;64(5):580-588. doi: 10.1093/cid/ciw845.

11.

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.

Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM, Chow EP, Cummings T, Drolet M, Fairley CK, Garland SM, Kahn JA, Kavanagh K, Markowitz L, Pollock KG, Söderlund-Strand A, Sonnenberg P, Tabrizi SN, Tanton C, Unger E, Thomas SL.

Emerg Infect Dis. 2016 Oct;22(10):1732-40. doi: 10.3201/eid2210.160675. Review.

12.

Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.

Canvin M, Sinka K, Hughes G, Mesher D.

Sex Transm Infect. 2017 Mar;93(2):125-128. doi: 10.1136/sextrans-2016-052626. Epub 2016 Jun 30.

PMID:
27365492
13.

HPV Serology Testing Confirms High HPV Immunisation Coverage in England.

Mesher D, Stanford E, White J, Findlow J, Warrington R, Das S, Pebody R, Borrow R, Soldan K.

PLoS One. 2016 Mar 9;11(3):e0150107. doi: 10.1371/journal.pone.0150107. eCollection 2016.

14.

Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study.

Mesher D, Panwar K, Thomas SL, Beddows S, Soldan K.

BMJ Open. 2016 Feb 11;6(2):e009915. doi: 10.1136/bmjopen-2015-009915.

15.

Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.

Lim A, Mesher D, Gentry-Maharaj A, Balogun N, Widschwendter M, Jacobs I, Sasieni P, Menon U.

BJOG. 2016 May;123(6):1012-20. doi: 10.1111/1471-0528.13447. Epub 2015 May 29.

16.

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.

Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M.

Lancet Infect Dis. 2015 May;15(5):565-80. doi: 10.1016/S1473-3099(14)71073-4. Epub 2015 Mar 3. Review.

17.
18.

Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.

Mesher D, Cuschieri K, Hibbitts S, Jamison J, Sargent A, Pollock KG, Powell N, Wilson R, McCall F, Fiander A, Soldan K.

J Clin Pathol. 2015 Feb;68(2):135-40. doi: 10.1136/jclinpath-2014-202681. Epub 2014 Nov 19.

PMID:
25410654
20.

Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England.

Mesher D, Soldan K, Howell-Jones R, Panwar K, Manyenga P, Jit M, Beddows S, Gill ON.

Vaccine. 2013 Dec 17;32(1):26-32. doi: 10.1016/j.vaccine.2013.10.085. Epub 2013 Nov 6.

21.

Declining genital Warts in young women in england associated with HPV 16/18 vaccination: an ecological study.

Howell-Jones R, Soldan K, Wetten S, Mesher D, Williams T, Gill ON, Hughes G.

J Infect Dis. 2013 Nov 1;208(9):1397-403. doi: 10.1093/infdis/jit361.

22.

A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer.

Mesher D, Dove-Edwin I, Sasieni P, Vasen H, Bernstein I, Royer-Pokora B, Holinski-Feder E, Lalloo F, Evans DG, Forsberg A, Lindblom A, Thomas H.

Int J Cancer. 2014 Feb 15;134(4):939-47. doi: 10.1002/ijc.28397. Epub 2013 Aug 29.

23.

Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities.

Mesher D, Szarewski A, Cadman L, Austin J, Ashdown-Barr L, Ho L, Terry G, Young M, Stoler M, Bergeron C, McCarthy J, Wright C, Liddle S, Soutter WP, Lyons D, Cuzick J.

Eur J Cancer. 2013 Jun;49(9):2179-86. doi: 10.1016/j.ejca.2013.01.018. Epub 2013 Feb 26.

24.

p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Matin RN, Chikh A, Chong SL, Mesher D, Graf M, Sanza' P, Senatore V, Scatolini M, Moretti F, Leigh IM, Proby CM, Costanzo A, Chiorino G, Cerio R, Harwood CA, Bergamaschi D.

J Exp Med. 2013 Mar 11;210(3):581-603. doi: 10.1084/jem.20121439. Epub 2013 Feb 18.

25.

Comparing the performance of six human papillomavirus tests in a screening population.

Cuzick J, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Ho L, Terry G, Liddle S, Wright C, Lyons D, Szarewski A.

Br J Cancer. 2013 Mar 5;108(4):908-13. doi: 10.1038/bjc.2013.22. Epub 2013 Jan 31.

26.

Characteristics of HPV infection over time in European women who are HIV-1 positive.

Heard I, Cubie HA, Mesher D, Sasieni P; MACH-1 Study Group.

BJOG. 2013 Jan;120(1):41-9. doi: 10.1111/1471-0528.12015. Epub 2012 Nov 2.

27.

A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population.

Harwood CA, Mesher D, McGregor JM, Mitchell L, Leedham-Green M, Raftery M, Cerio R, Leigh IM, Sasieni P, Proby CM.

Am J Transplant. 2013 Jan;13(1):119-29. doi: 10.1111/j.1600-6143.2012.04292.x. Epub 2012 Oct 16.

28.

The prognostic value of Ki-67 expression in penile squamous cell carcinoma.

Stankiewicz E, Ng M, Cuzick J, Mesher D, Watkin N, Lam W, Corbishley C, Berney DM.

J Clin Pathol. 2012 Jun;65(6):534-7. doi: 10.1136/jclinpath-2011-200638. Epub 2012 Mar 23.

PMID:
22447920
29.

Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.

Szarewski A, Mesher D, Cadman L, Austin J, Ashdown-Barr L, Ho L, Terry G, Liddle S, Young M, Stoler M, McCarthy J, Wright C, Bergeron C, Soutter WP, Lyons D, Cuzick J.

J Clin Microbiol. 2012 Jun;50(6):1867-73. doi: 10.1128/JCM.00181-12. Epub 2012 Mar 14.

30.

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

Cuzick J, Berney DM, Fisher G, Mesher D, Møller H, Reid JE, Perry M, Park J, Younus A, Gutin A, Foster CS, Scardino P, Lanchbury JS, Stone S; Transatlantic Prostate Group.

Br J Cancer. 2012 Mar 13;106(6):1095-9. doi: 10.1038/bjc.2012.39. Epub 2012 Feb 23.

31.

Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.

Lim AW, Mesher D, Gentry-Maharaj A, Balogun N, Jacobs I, Menon U, Sasieni P.

J Natl Cancer Inst. 2012 Jan 18;104(2):114-24. doi: 10.1093/jnci/djr486. Epub 2012 Jan 13. Erratum in: J Natl Cancer Inst. 2013 Dec 4;105(23):1841.

PMID:
22247022
32.

Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole.

Singh S, Cuzick J, Mesher D, Richmond B, Howell A.

Breast Cancer Res Treat. 2012 Apr;132(2):625-9. doi: 10.1007/s10549-011-1911-6. Epub 2011 Dec 25.

PMID:
22198469
33.

13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010.

Parkin DM, Mesher D, Sasieni P.

Br J Cancer. 2011 Dec 6;105 Suppl 2:S66-9. doi: 10.1038/bjc.2011.486. No abstract available.

34.

Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial.

Castañon A, Tristram A, Mesher D, Powell N, Beer H, Ashman S, Rieck G, Fielder H, Fiander A, Sasieni P.

Br J Cancer. 2012 Jan 3;106(1):45-52. doi: 10.1038/bjc.2011.496. Epub 2011 Nov 10.

35.

Single negative colposcopy: is it enough to rule out high-grade disease?

Mesher D, Tristram A, Castanon A, Beer H, Ashman S, Fielder H, Fiander A, Sasieni P.

J Med Screen. 2011;18(3):160-1. doi: 10.1258/jms.2011.011097.

PMID:
22045826
36.

Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas.

Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, Lu YJ, Watkin N, Corbishley C, Lam W, Berney DM.

PLoS One. 2011 Mar 2;6(3):e17517. doi: 10.1371/journal.pone.0017517.

37.

HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.

Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, Lyons D, Walker J, Christison J, Frater A, Waller J.

Br J Cancer. 2011 Mar 15;104(6):915-20. doi: 10.1038/bjc.2011.48. Epub 2011 Feb 22.

38.

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

Cuzick J, Swanson GP, Fisher G, Brothman AR, Berney DM, Reid JE, Mesher D, Speights VO, Stankiewicz E, Foster CS, Møller H, Scardino P, Warren JD, Park J, Younus A, Flake DD 2nd, Wagner S, Gutin A, Lanchbury JS, Stone S; Transatlantic Prostate Group.

Lancet Oncol. 2011 Mar;12(3):245-55. doi: 10.1016/S1470-2045(10)70295-3.

39.

Assessing Peanut Consumption in a Population of Mothers and Their Children in the UK.

Sofianou-Katsoulis A, Mesher D, Sasieni P, Du Toit G, Fox AT, Lack G.

World Allergy Organ J. 2011 Feb;4(2):38-44. doi: 10.1097/WOX.0b013e318205ab27. Epub 2011 Feb 23.

40.

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study.

Mesher D, Szarewski A, Cadman L, Cubie H, Kitchener H, Luesley D, Menon U, Hulman G, Desai M, Ho L, Terry G, Williams A, Sasieni P, Cuzick J.

Br J Cancer. 2010 Apr 27;102(9):1405-10. doi: 10.1038/sj.bjc.6605619. Epub 2010 Mar 30.

41.

Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy.

Du Toit G, Katz Y, Sasieni P, Mesher D, Maleki SJ, Fisher HR, Fox AT, Turcanu V, Amir T, Zadik-Mnuhin G, Cohen A, Livne I, Lack G.

J Allergy Clin Immunol. 2008 Nov;122(5):984-91. doi: 10.1016/j.jaci.2008.08.039.

PMID:
19000582
42.

Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases.

Matin RN, Mesher D, Proby CM, McGregor JM, Bouwes Bavinck JN, del Marmol V, Euvrard S, Ferrandiz C, Geusau A, Hackethal M, Ho WL, Hofbauer GF, Imko-Walczuk B, Kanitakis J, Lally A, Lear JT, Lebbe C, Murphy GM, Piaserico S, Seckin D, Stockfleth E, Ulrich C, Wojnarowska FT, Lin HY, Balch C, Harwood CA; Skin Care in Organ Transplant Patients, Europe (SCOPE) group.

Am J Transplant. 2008 Sep;8(9):1891-900. doi: 10.1111/j.1600-6143.2008.02326.x.

43.

Beta-papillomaviruses and psoriasis: an intra-patient comparison of human papillomavirus carriage in skin and hair.

Cronin JG, Mesher D, Purdie K, Evans H, Breuer J, Harwood CA, McGregor JM, Proby CM.

Br J Dermatol. 2008 Jul;159(1):113-9. doi: 10.1111/j.1365-2133.2008.08627.x. Epub 2008 Jul 1.

44.

Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.

Cuzick J, Szarewski A, Mesher D, Cadman L, Austin J, Perryman K, Ho L, Terry G, Sasieni P, Dina R, Soutter WP.

Int J Cancer. 2008 May 15;122(10):2294-300. doi: 10.1002/ijc.23339.

45.

Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.

Kitchener H, Nelson L, Adams J, Mesher D, Sasieni P, Cubie H, Moore C, Heard I, Agarossi A, Casolati E, Denny L, Bradbeer C, Lyons F, Beattie G, Niemiec T.

Int J Cancer. 2007 Dec 1;121(11):2484-91.

46.

Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.

Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, Vasen HF, Thomas HJ.

Gastroenterology. 2006 Jun;130(7):1995-2000.

PMID:
16762622

Supplemental Content

Loading ...
Support Center